|
|
Volumn 19, Issue 9, 2008, Pages 1656-1657
|
|
Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity
a,d
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE;
CREATINE KINASE;
FATTY ACID BINDING PROTEIN;
GLYCOGEN PHOSPHORYLASE;
GLYCOGEN PHOSPHORYLASE BB;
HEART TYPE FATTY ACID BINDING PROTEIN;
MYOGLOBIN;
TROPONIN I;
TROPONIN T;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
ARTICLE;
CANCER CHEMOTHERAPY;
CARDIOTOXICITY;
CLINICAL ARTICLE;
CLINICAL ASSESSMENT;
DIAGNOSTIC VALUE;
DISEASE MARKER;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG MEGADOSE;
FEMALE;
HEART INJURY;
HUMAN;
INJURY SCALE;
MALE;
MULTIPLE CYCLE TREATMENT;
PRIORITY JOURNAL;
TREATMENT DURATION;
TREATMENT OUTCOME;
ADULT;
ANTHRACYCLINES;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL MARKERS;
COHORT STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GLYCOGEN PHOSPHORYLASE;
HEART DISEASES;
HUMANS;
LEUKEMIA, MYELOID, ACUTE;
MALE;
MIDDLE AGED;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SURVIVAL RATE;
|
|
EID: 50849090569
PISSN: 09237534
EISSN: 15698041
Source Type: Journal
DOI: 10.1093/annonc/mdn414 Document Type: Article |
|
Times cited : (27)
|
|
References (5)
|
